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Purpose: The pathogenesis of abdominal aortic aneurysm (AAA) involves many factors; 
elastin degradation is believed to lead to initial dilation, whereas changes in the collagen 
structure predispose the aneurysm to rupture. The major collagens in the aortic wall are 
types I and III. We set out here to determine whether changes in serum propeptide of type 
III procollagen (PIIINP), a biologically relevant marker of type III collagen turnover, 
could be associated with the characteristics of AAA. 
Methods: The aminoterminal PII INP and the carboxyterminal propeptide of type I 
collagen were measured by radioimmunoassay in 87 patients with AAA and 90 control 
subjects with aortodistal arteriosclerosis. The samples were taken from the peripheral 
blood and from the abdominal aorta at the levels of the diaphragm and the common iliac 
artery. 
Results: Mean PIIINP concentrations were higher in patients with AAA than in control 
subjects (3.47 ~g/L vs 2.73 I,g/L, p < 0.0001), correlating positively with aneurysm 
diameter in the former (r = 0.27, p = 0.04) and with the maximum thickness of the 
intraluminal thrombus (r = 0.39,p = 0.003). The gradient in PIIINP between the upper 
and lower end of the abdominal aorta was significant in the AAA group ( -0 .30 ~g/L, 
range -0.20 to -0 .50 vs -0 .10 ~g/L, range -0 .20 to 0.30,p = 0.002). 
Conclusions: These studies indicate that the turnover of type III collagen is increased in 
patients with AAA. (J VAsc SURG 1995;22:155-60.) 
The pathogenesis of abdominal aortic aneurysm 
(AAA) is largely unknown, although degradation of 
the elastin in the aortic wall has been shown to impair 
the compliancc of the arterial wall, which may lead to 
aneurysmal dilation.1 The collagen of the aortic wall 
provides its tensile strength, and it has been suggested 
that changes in the structure of the collagen may 
predispose the aneurysm to rupture. 1,2 Quantita- 
tively, the major types of collagen in the aortic wall 
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are types I and III, with its tensile characteristics 
mainly the result of  the latter, a
As a part of the procollagen molecule, the 
aminoterminal propeptide of type 1II procollagen 
(PIIINP) is liberated into the extracellular fluid 
during its processing to collagen 4 and is measurable 
in the serum in steady states of turnover, that is in the 
absence of any cause for enhanced synthesis or 
catabolism of type III collagen. 4 Some molecules till 
retaining the PII INP are located on the surface of  
collagen fibrils, where they are relatively susceptible 
to proteolytic attack, s but these pN-collagen mol- 
ecules are small in number as compared with the main 
mass of the corresponding collagen fibrils, s However, 
degradation of pN-collagen molecules in association 
with the breakdown of collagen fibrils may lead to a 
rapid, detectable increase in serum PIIINP, whereas 
more gradual changes can be indicative of alterations 
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in the synthesis rate. 6,7 The carboxyterminal propep- 
tide of type I procollagen (PICP) is totally cleaved off 
during processing, and PICP is considered purely a 
marker of type I collagen synthesis. 8,9 
Type III collagen is a potent inducer of platelet 
aggregation when exposed to blood elements and 
may play a specific role in thrombogenesis.10 Intralu- 
minal thrombus is frequently encountered in AAA. 
On the other hand, plasmin is shown to activate 
latent tissue collagenases capable of degrading the 
interstitial collagen types I and 111.11 Evidence has 
been put forward that thrombus and degradation of 
collagen coexist in the arterial wall, 12 and it is 
conceivable that this could play a role in aneurysm 
formation and events in the arterial wall that lead to 
aneurysmal rupture. 
We set out here to determine whether changes in 
serum PIIINP, a biologically relevant marker of type 
III collagen turnover, could be associated with the 
characteristics of AAA. We hoped to demonstrate he 
following: a general increase in collagen turnover in 
patients with AAA by measuring PIIINP concentra- 
tions in peripheral venous blood; an association of 
serum PIIINP with the size of the aneurysm and the 
thrombus within it; and locally increased turnover of 
collagen in the aneurysm itself by measuring PIIINP 
levels in the aorta above and below the aneurysm sac. 
PATIENTS AND METHODS 
The series was composed of 87 consecutive 
patients (73 men, 14 women, mean age 69.9 years, 
SD 8.6, range 45 to 70) who were admitted to Oulu 
University Hospital from January to October 1993 
with a diagnosis of AAA. Most of the symptom-free 
patients were sent to consult with a vascular surgeon 
after incidental finding of an AAA by a general 
physician. Patients undergoing emergency operation 
for a ruptured aneurysm were outlined in this series. 
In every instance the abdominal aorta was visualized 
by B-mode ultrasonography, and the dimensions of 
the aneurysm and thrombotic mass were determined. 
Twenty-nine patients with femorodistal rterio- 
sclerotic disease (FDD) (14 men, 15 women, mean 
age 72.3 years, standard eviation (SD) 11.2, range 
45 to 96) and 61 with aortoiliac occlusive disease 
(AOD) (46 men, 15 women, mean age 64.4 years, 
SD 9.1, range 43 to 84) were recruited as control 
subjects. A venous blood sample was taken in each 
case. One-way analysis of variance showed that the 
mean age varied significantly between the groups 
(f = 9.3, p = 0.0002), with that of patients with 
AOD being more than 5 years less than the others. 
Patients with a history of any condition known to 
interfere with collagen metabolism, such as liver 
fibrosis, or any malignancy or who underwent an 
operation less than a year before sampling were 
excluded.9,13-I5 
So far 13 of 87 patients in the AAA group have 
met the criteria for elective surgery and have under- 
gone preoperative aortography. These patients had 
AAA-related symptoms uch as pain or aneurysm 
diameter of more than 50 ram. During this procedure 
aortic blood samples were obtained from above and 
below the aneurysm (from the aorta at the level of the 
diaphragm and iliac artery respectively) with 30 
seconds of aspiration. Thirteen patients from the 
AOD group who had also undergone aortography 
and aortic blood sampling at the same levels were 
selected to act as age- and sex-matched control 
subjects. 
The concentration of PIIINP was analyzed with 
an equilibrium-type radioimmunoassay I6 based on 
human antigen (Orion Diagnostica, Oulunsalo, Fin- 
land) with use of duplicate 200 ~1 aliquots of serum. 
The assay detects the authentic propeptide and 
another, somewhat larger related collagenous anti- 
gen, but it is not sensitive to the smaller degradation 
products of the propeptide. The proportion of the 
antigens in serum seems to be stable if the concen- 
tration increases in the same individual. 7The anti- 
gens are resistant to repetitive thawing and freezing. 
The benefit of this new assay method compared with 
previously reported assays for PIIINP is that the 
standards and serum samples give parallel inhibition 
curves. The procedure takes 3 to 4 hours to perform, 
with intraassay and interassay variations of about 5 %. 
The sensitivity of the PIIINP assay, defined as the 
detectable mass equivalent to twice the mean + SD 
of the zero binding value, was 0.2 ~g/L. The 
reference range for adults, based on data for 88 
Finnish blood donors, was 1.7 to 4.2 ~g/L, with no 
difference on the basis of sex. 
The concentration of PICP was assayed with a 
similar radioimmunoassay established by Mell&o et 
al.17 Serum PICP concentrations for persons between 
18 and 61 years of age are 50 to 170 ~g/L for women, 
and 38 to 202 ~g/L for men. 
The data storage and statistical analyses were 
performed with Statistica Software Rel. 4.5 (Stat- 
Soft, Inc., Tulsa, Olda.). Parametric methods were 
used for the summary measures and comparisons 
(one-way analysis of variance) between the main 
groups (AAA, FDD, and AOD). Correlations were 
calculated by use of the Pearson product moment 
correlation coefficient. The 13 matched pairs of 
patients with AAA and AOD were compared by use 
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Fig. 1. Concentration of PIIINP in peripheral venous 
blood of patients with AAA and two groups of control 
subjects (FDD, AOD); mean, standard error of mean, and 
95% confidence intervals of mean are shown. For statistical 
comparison, one-way analysis of variance was used.Asterisk 
denotes p < 0.05, and four asterisks denote p < 0.000l. 
of the nonparametric Wilcoxon matched pairs test 
because of a relatively small sample size and appar- 
ently nonnormal distribution of the differences 
between the values of PII INP high and low in the 
aorta. Medians and ranges of the pairs are shown. The 
study plan was approved by the Ethical Committee of 
the Medical Faculty of Oulu. 
RESULTS 
The maximum diameter of  the aneurysm varied 
between 2.4 cm and 7.0 cm, mean 4.1 cm, and its 
mean length was 6.6 cm (range 3.0 to 11.0). There 
was a positive correlation between diameter and 
length (r = 0.43,p = 0.001). The mean thickness of 
the intraaneurysmal thrombus was 1.9 cm (range 0.4 
to 4.0), and this showed a positive correlation with 
both the diameter and length of the aneurysm 
(r = 0.28, p = 0.04 and r = 0.51, p < 0.0001, 
respectively). 
The mean concentrations of PII INP in the 
peripheral venous blood in the patients with AAA 
and the control groups are shown in Fig. 1. The levels 
in the patients with AAA seems to be higher, and the 
difference is highly significant in one-way analysis of 
variance ( f=  13.7, p < 0.0001). There were no 
differences in mean serum PII INP concentration 
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Fig. 2. Correlations between age of patient and serum 
PIIINP concentration i patients with AAA, control 
subjects with FDD and control subjects with AOD. 
Pearson product moment correlation coefficient, regres- 
sion line with 95% confidence limits. 
between the women and men in any subgroup, but 
there does seem to be a slight increase in the serum 
PII INP level with increasing age of the patient (Fig. 
2). In the FDD group, with a sample size of  only 29 
patients, statistical significance was not reached. 
Serum PII INP values had a slight positive correlation 
with aneurysm diameter (r = 0.27, p = 0.04) (Fig. 
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Fig. 3. Correlation between serum PIIINP concentration and diameter of aneurysm in 87 
patients with AAA. Pearson product moment correlation coefficient was used. 
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Fig. 4. Correlation between serum PIIINP concentration and thickness of intraluminal 
thrombus in 87 patients with AAA. Pearson product moment correlation coefficient was used. 
3), but a more distinct correlation was found with the 
maximum thickness of the intraluminal thrombus 
(r = 0.39,p = 0.003) (Fig. 4). 
The median venous P I I INP concentrations for 
the 13 patients with AAA and their matched control 
subjects with AOD were 3.5 txg/L (range 2.4 to 6.8 
txg/L) and 3.1 txg/L (range 2.0 to 4.9 Ixg/L), 
respectively; the median concentration at the upper 
level in the aorta was 3.2 txg/L (range 2.0 to 5.2 
txg/L) and 2.4 txg/L (range 1.6 to 3.7 Ixg/L) 
(z = 1.1,p = 0.26), respectively, and the concentra- 
tion below the aneurysm level was higher, 3.4 Ixg/L 
(range 2.5 to 5.5 txg/L), in the AAA group but 
identical in the AOD group, 2.4 Ixg/L (range 1.5 to 
3.8 ~xg/L) (Fig. 5). Thus the gradient of the P I I INP 
concentration between the upper and lower ends of 
the abdominal aorta was - 0.30 Ixg/L (range - 0.20 
to - 0.50 ~xg/L) in the AAA group and - 0.10 txg/L 
( - 0.20 to 0.30 Ixg/L) in the AOD group, which was 
a statistically significant difference (z = 3.1, p = 
0.002, Wilcoxon matched pairs test). 
The PICP concentration was generally higher in 
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Fig. 5. PIIINP concentrations in aorta above and below aneurysm in patients with AAA (A) 
and at diaphragm and iliac levels in aorta in patients with AOD (B) in 13 age- and sex-matched 
pairs. Horizontal ines in A denote median above (continuous line) and below (broken line) 
aneurysm. Median concentrations atdiaphragm and iliac levels in AOD group (B) were equal 
(continuous line);z - 3.1, p = 0.002, Wilcoxon matched pairs test, for difference of gradient 
between groups. 
peripheral venous blood than in the aorta in the 13 
matched AAA-AOD pairs. The mean concentrations 
in peripheral blood in AAA and AOD groups were 
107 t*g/L (range 69 to 146 ~g/L) and 103 btg/L 
(range 66 to 159 t,g/L), respectively. The concen- 
trations over the different levels of aorta did not vary, 
however. The mean concentrations above and below 
the aneurysm were 96 t,g/L (range 62 to 121 t,g/L) 
and 98 ~g/L (range 62 to 126 I,g/L). The respective 
values high and low in aorta in the AOD group were 
97 t,g/L (range 62 to 150 t,g/L) and 97 ~g/L (range 
62 to 145 Izg/L). 
DISCUSSION 
The results demonstrate hat the turnover of type 
III collagen is increased in patients with AAA and 
may be due to enhanced synthesis, enhanced egra- 
dation, or a combination of both. 
The mean levels of PIIINP in the peripheral 
venous blood were distinctly higher in the patients 
with AAA than in the control subjects. Age was 
found overall to be associated with the serum PIIINP 
concentrations, but the Fact that the control subjects 
with aortoiliac arteriosclerosis were younger than the 
patients with AAA could scarcely explain the major 
finding, because the other control group of distal 
lower extremity arteriosclerosis cases had an equal 
distribution by age. Both control groups, however, 
had equal PIIINP levels that were distinctly lower 
than in the patients with AAA, suggesting that the 
difference is due to the aneurysm per se. The overall 
levels of PIIINP in the control subjects are in line 
with previous reports for normal populations. 16
Furthermore, the clear differences between the aortic 
values for the patients with AAA and AOD very 
strongly suggest that the liberation of PIIINP from 
the abdominal aortic segment is enhanced in aneu- 
rysm disease relative to occlusive disease. 
The PICP values did not reveal any accelerated 
synthesis of type I collagen in the aneurysm sac, and 
this is probably also true of all the other collagens. 12 
The different behavior of PICP and PIIINP is 
noteworthy because they are biochemically very 
similar molecules. At least, it ascertains increased 
turnover of PIIINP in the aneurysm. Preferably, it 
could refer to degradation of type III pN collagen 
because PICP is a pure synthesis marker. 6 
Serum PIIINP values correlated positively with 
the maximum thickness of the intraluminal throm- 
bus, a finding that raises questions regarding the 
pathogenesis ofaneurysms. These findings are in line 
with a recent investigation suggesting that fibrinoly- 
sis could cause degradation of collagens. 12 An onion- 
shaped thrombus is encountered in almost every case 
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of  AAA and may be a source of  local physiologic 
fibrinolysis, during which activators originating from 
the blood vessel endothelium convert plasminogen to 
active plasmin, which in turn is known to act as an 
unspecific proteinase and to possess collagenase- 
activating properties.18 
The natural course of  AAA disease is to proceed 
to a catastrophic rupture, which is known to be the 
cause of  1.3% of  all deaths in men older than 65 years 
o f  age. 19 The only parameter having a clearly 
predictive value with respect o this catastrophe until 
recently has been the maximum outer diameter o f  the 
aneurysm, and in almost every case this has been the 
only criterion on which to judge the timing o f  an 
operation. 2°'21 The rate o f  growth of  an aneurysm can 
vary even within same individual, however, and some 
may be quiescent for months or years and then 
enlarge rapidly. = In any case, aneurysms of  less than 
4 cm have also been found to rupture. 2a Evaluation 
of  the risk o f  rupture in the case of  a small aneurysm 
is a sophisticated matter, because no marker predict- 
ing this risk is available other than the expansion rate 
and maximum diameter. Previous suggestions that 
type 1II collagen fragmentation may lead to aneu- 
rysm rupture give additional impact to these find- 
ings, 1 and to our knowledge, this work represents the 
first attempt o monitor  events that might bear some 
relevance to aneurysm rupture. Serial arterial mea- 
surements (iliac puncture) could be tested as a 
possible marker o f  events in the aneurysm. 
In  conclusion, the turnover o f  type I l i  collagen 
was increased in patients with AAA, as shown by 
increased levels o f  P I I INP  in the peripheral venous 
blood. The gradient over the aneurysm suggests that 
at least part o f  the difference is due to events in this 
area. The clinical significance of  the finding should 
now be verified by means of  serial measurements in 
the same patients. 
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